Live birth rate · women with endometriosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Overall pain ‐ 3 months · women with endometriosis
1 finding from 1 review
Adverse events · women with endometriosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Overall pain · women with endometriosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clinical pregnancy rate · women with endometriosis
It is very uncertain whether pentoxifylline changes clinical pregnancy rate compared with placebo (very low certainty).
1 finding from 1 review
Miscarriage · women with endometriosis
It is very uncertain whether pentoxifylline changes miscarriage rate compared with placebo (very low certainty).
1 finding from 1 review
Recurrence rate of endometriosis · women with endometriosis
It is very uncertain whether pentoxifylline changes recurrence rate of endometriosis compared with placebo (very low certainty).
1 finding from 1 review
Adverse events · women with endometriosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Live birth rate · women with endometriosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Overall pain ‐ 1 month · women with endometriosis
1 finding from 1 review
Overall pain ‐ 2 months · women with endometriosis
1 finding from 1 review
PFWD (change in metres) (4–40 weeks' · intermittent claudication
1 finding from 1 review
TWD (change in metres) (8–52 weeks' · intermittent claudication
1 finding from 1 review
ABI (pre‐exercise/baseline ABI compared with · intermittent claudication
1 finding from 1 review
QoL · intermittent claudication
1 finding from 1 review
Side effects (number of cases or proportion) (4–52 weeks' · intermittent claudication
1 finding from 1 review
Health‐related quality of life · participants with alcoholic hepatitis (all severity)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mortality at maximal · participants with severe alcoholic hepatitis
It is very uncertain whether pentoxifylline changes mortality at maximal compared with no intervention (very low certainty).
1 finding from 1 review
Early mortality (mortality up to 90 days) · participants with severe alcoholic hepatitis
It is very uncertain whether pentoxifylline changes early mortality (mortality up to 90 days) compared with no intervention (very low certainty).
1 finding from 1 review
Serious adverse events (proportion) · participants with severe alcoholic hepatitis
It is very uncertain whether pentoxifylline changes serious adverse events (proportion) compared with no intervention (very low certainty).
1 finding from 1 review